First German IPO of the year.
Register for further information on Germany’s first IPO of the year from a pharmaceutical company raising EUR 350 million.
The offer period is expected to end 8th February.
The company is leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas with 900 marketing authorisations.
Register your interest now to receive further details
Register your interest today:
This Research is a marketing communication. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is also not subject to any prohibition on dealing ahead of the dissemination of investment research, although as a matter of policy Ocean Capital Group requires its employees not to deal ahead of the dissemination of the report.
Ocean Capital Group is a trading name of TS Capital Ltd who is authorised and regulated by the Financial Conduct Authority (FRN: 447281). Registered Office: Ocean Capital Group / TS Capital Ltd, 4th Floor, 6 Lloyds Avenue, London EC3N 3AX
All investments contain an element of risk therefore the value of investments, and the income from them can fall as well as rise, and you may get back less than you invested. An investment’s past performance is not a reliable indicator of future performance. Tax treatment depends on your individual circumstances and may be subject to change in the future. If in any doubt please seek further independent advice.
The information on this site is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.